| NCT03252405 |
Effect of Induction Method in Post Operative Agitation |
https://ClinicalTrials.gov/show/NCT03252405 |
Completed |
Ahi Evran University Education and Research Hospital |
2017-10-30 |
| NCT03317067 |
Effects of Dexmedetomidine on Delirium Duration of Non-intubated ICU Patients (4D Trial) |
https://ClinicalTrials.gov/show/NCT03317067 |
Recruiting |
University Hospital, Clermont-Ferrand |
2021-12-21 |
| NCT03393520 |
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer’s Type |
https://ClinicalTrials.gov/show/NCT03393520 |
Recruiting |
Avanir Pharmaceuticals |
2021-06-30 |
| NCT03337529 |
Restless Legs Syndrome in Hemodialysis Patients |
https://ClinicalTrials.gov/show/NCT03337529 |
Completed |
Makassed General Hospital |
2018-04-15 |
| NCT03328676 |
The Effect of Cannabis on Dementia Related Agitation and Aggression |
https://ClinicalTrials.gov/show/NCT03328676 |
Recruiting |
TO Pharmaceuticals |
2019-11-30 |
| NCT03249779 |
Treatment of RLS/WED Symptoms Through Sensory Counter-stimulation |
https://ClinicalTrials.gov/show/NCT03249779 |
Completed |
Mayo Clinic |
2018-06-30 |
| NCT03246620 |
Oral Olanzapine Versus Haloperidol or Diazepam |
https://ClinicalTrials.gov/show/NCT03246620 |
Recruiting |
The University of Hong Kong |
2020-12-31 |
| NCT03218969 |
Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist |
https://ClinicalTrials.gov/show/NCT03218969 |
Active, not recruiting |
The Methodist Hospital System |
2018-09-15 |
| NCT03216941 |
Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward |
https://ClinicalTrials.gov/show/NCT03216941 |
Completed |
Universidad Nacional de Rosario |
2016-01-01 |
| NCT03208452 |
The Effect of Intraoperative Magnesium Sulfate Infusion on the Occurrence of Emergence Agitation |
https://ClinicalTrials.gov/show/NCT03208452 |
Completed |
Seoul National University Bundang Hospital |
2018-12-19 |
| NCT03179293 |
Transition to Propofol After Sevoflurane Anaesthesia to Prevent Emergence Agitation |
https://ClinicalTrials.gov/show/NCT03179293 |
Completed |
Assiut University |
2018-06-01 |
| NCT03171740 |
Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children |
https://ClinicalTrials.gov/show/NCT03171740 |
Completed |
Brasilia University Hospital |
2017-12-01 |
| NCT03134547 |
A Comparison of Emergence Agitation by Sevoflurane for Intraoperative Sedation Associated With Caudal Block |
https://ClinicalTrials.gov/show/NCT03134547 |
Completed |
Yeungnam University College of Medicine |
2016-12-31 |
| NCT03118947 |
A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer’s Disease |
https://ClinicalTrials.gov/show/NCT03118947 |
Completed |
ACADIA Pharmaceuticals Inc. |
2019-02-25 |
| NCT03108846 |
Escitalopram for Agitation in Alzheimer’s Disease |
https://ClinicalTrials.gov/show/NCT03108846 |
Recruiting |
JHSPH Center for Clinical Trials |
2021-12-31 |
| NCT03095066 |
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury |
https://ClinicalTrials.gov/show/NCT03095066 |
Active, not recruiting |
Avanir Pharmaceuticals |
2020-06-30 |
| NCT03069027 |
Efficacy of External Nasal Nerve Block in Prevention of Postoperative Agitation Following Nasal Surgeries |
https://ClinicalTrials.gov/show/NCT03069027 |
Completed |
Al Jedaani Hospital |
2017-04-15 |
| NCT03062488 |
Emergence Agitation and Pain Scores in Pediatrics When Comparing Single-modal vs Multi-modal Analgesia for ENT Surgery |
https://ClinicalTrials.gov/show/NCT03062488 |
Completed |
Nemours Children’s Clinic |
2018-07-11 |
| NCT03053427 |
A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients |
https://ClinicalTrials.gov/show/NCT03053427 |
Completed |
Astellas Pharma Inc |
2018-06-25 |
| NCT02943213 |
Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride |
https://ClinicalTrials.gov/show/NCT02943213 |
Completed |
Cycle Pharmaceuticals Ltd. |
2016-12-31 |
| NCT02917018 |
Effect of Dexmedetomidine on Stress Response and Emergence Agitation During Laparoscopic Surgery |
https://ClinicalTrials.gov/show/NCT02917018 |
Completed |
Assiut University |
2016-12-31 |
| NCT02909465 |
Reducing Ketamine-Induced Agitation, by Midazolam or Haloperidol Premedication After Adult Procedural Sedation |
https://ClinicalTrials.gov/show/NCT02909465 |
Completed |
Tehran University of Medical Sciences |
2017-04-30 |
| NCT02848963 |
Comparison of Ketamine-propofol Combinations |
https://ClinicalTrials.gov/show/NCT02848963 |
Completed |
Cukurova University |
2017-02-28 |
| NCT02826681 |
Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia |
https://ClinicalTrials.gov/show/NCT02826681 |
Recruiting |
American Regent, Inc. |
2021-03-31 |
| NCT02757495 |
Can Caudal Dexmedetomidine Prevents Sevoflurane Induced Emergence Agitation in Children |
https://ClinicalTrials.gov/show/NCT02757495 |
Completed |
Suez Canal University |
2017-04-30 |
| NCT02720705 |
Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children |
https://ClinicalTrials.gov/show/NCT02720705 |
Recruiting |
Assiut University |
2018-10-31 |
| NCT02658188 |
Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients |
https://ClinicalTrials.gov/show/NCT02658188 |
Completed |
Astellas Pharma Inc |
2009-04-30 |
| NCT02642315 |
The Effect of Horizant (Gabapentin Enacarbil) on Augmentation |
https://ClinicalTrials.gov/show/NCT02642315 |
Completed |
University of Missouri-Columbia |
2019-05-06 |
| NCT02613052 |
Agitated Saline, Albumin, or Propofol-albumin Mixture for Enhanced Contrast in TEE Examinations |
https://ClinicalTrials.gov/show/NCT02613052 |
Completed |
University of California, San Diego |
2017-06-30 |
| NCT02612948 |
Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients |
https://ClinicalTrials.gov/show/NCT02612948 |
Completed |
University of Tennessee Graduate School of Medicine |
2014-06-30 |
| NCT01922258 |
Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer’s Type |
https://ClinicalTrials.gov/show/NCT01922258 |
Completed |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2017-03-31 |
| NCT03398759 |
Butorphanol Mitigate Emergence Agitation in Patients Undergoing Functional Endoscopic Sinus Surgery |
https://ClinicalTrials.gov/show/NCT03398759 |
Recruiting |
RenJi Hospital |
2020-12-31 |
| NCT02532608 |
Infra-slow Oscillations During Sleep |
https://ClinicalTrials.gov/show/NCT02532608 |
Completed |
Neurocenter of Southern Switzerland |
2017-08-31 |
| NCT02526277 |
A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome |
https://ClinicalTrials.gov/show/NCT02526277 |
Completed |
Ohio State University |
2018-09-25 |
| NCT02525991 |
Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting |
https://ClinicalTrials.gov/show/NCT02525991 |
Recruiting |
Ferrer Internacional S.A. |
2020-03-31 |
| NCT02524067 |
Modified Environment for Agitation in Patients With TBI |
https://ClinicalTrials.gov/show/NCT02524067 |
Completed |
University of Aarhus |
2018-05-31 |
| NCT02499354 |
Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA) |
https://ClinicalTrials.gov/show/NCT02499354 |
Recruiting |
Auerbach Hematology Oncology Associates P C |
2020-07-31 |
| NCT02463929 |
Dyphenhidramine Effect on Prevention of Sevoflurane Induced Post Anesthesia Agitation in Pediatric |
https://ClinicalTrials.gov/show/NCT02463929 |
Completed |
Universitas Diponegoro |
2014-06-30 |
| NCT02446132 |
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer’s Type |
https://ClinicalTrials.gov/show/NCT02446132 |
Recruiting |
Avanir Pharmaceuticals |
2022-06-30 |
| NCT02442778 |
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer’s Type |
https://ClinicalTrials.gov/show/NCT02442778 |
Completed |
Avanir Pharmaceuticals |
2019-08-14 |
| NCT02442765 |
Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer’s Type |
https://ClinicalTrials.gov/show/NCT02442765 |
Completed |
Avanir Pharmaceuticals |
2019-01-30 |
| NCT02428283 |
Scalp Nerve Block on Emergence Agitation |
https://ClinicalTrials.gov/show/NCT02428283 |
Completed |
Ajou University School of Medicine |
2016-11-30 |
| NCT02397057 |
Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS |
https://ClinicalTrials.gov/show/NCT02397057 |
Active, not recruiting |
American Regent, Inc. |
2018-04-18 |
| NCT02386423 |
RESTIFFICâ„¢ Foot Wrap Reduces Moderate to Severe Restless Leg Syndrome |
https://ClinicalTrials.gov/show/NCT02386423 |
Completed |
Lake Erie Research Institute |
2011-04-30 |
| NCT02383004 |
Acupuncture for the Prevention of Emergence Delirium in Children Undergoing Myringotomy Tube Placement |
https://ClinicalTrials.gov/show/NCT02383004 |
Completed |
Oregon Health and Science University |
2016-11-30 |
| NCT02361476 |
Does Intraoperative Clonidine Reduce Post Operative Agitation in Children? |
https://ClinicalTrials.gov/show/NCT02361476 |
Completed |
Rigshospitalet, Denmark |
2015-12-31 |
| NCT02256358 |
Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation |
https://ClinicalTrials.gov/show/NCT02256358 |
Completed |
Inje University |
2014-01-31 |
| NCT02231918 |
Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS) |
https://ClinicalTrials.gov/show/NCT02231918 |
Completed |
Boehringer Ingelheim |
2007-07-31 |
| NCT02202720 |
Evaluation of Richmond Agitation Sedation Scale According to Alveolar Concentration of Sevoflurane During a Sedation With Sevoflurane in ICU Patients |
https://ClinicalTrials.gov/show/NCT02202720 |
Completed |
University Hospital, Clermont-Ferrand |
2014-11-30 |
| NCT02199262 |
Quality Improving Program on Agitation in the Surgical Intensive Care Unit |
https://ClinicalTrials.gov/show/NCT02199262 |
Completed |
University Hospital, Geneva |
2005-01-31 |
| NCT02181543 |
Use of Intraoperative Clonidine for Prevention of Postoperative Agitation in Pedriatic Anesthesia With Sevoflurane. |
https://ClinicalTrials.gov/show/NCT02181543 |
Completed |
Professor Fernando Figueira Integral Medicine Institute |
2014-12-31 |
| NCT02147652 |
Personalized Music Therapy and Agitation in Dementia |
https://ClinicalTrials.gov/show/NCT02147652 |
Enrolling by invitation |
University Health Network, Toronto |
2020-06-30 |
| NCT02129348 |
Treatment of Psychosis and Agitation in Alzheimer’s Disease |
https://ClinicalTrials.gov/show/NCT02129348 |
Completed |
New York State Psychiatric Institute |
2020-01-31 |
| NCT02098499 |
Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the Emergency Department: A Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT02098499 |
Completed |
United States Naval Medical Center, Portsmouth |
2014-02-28 |
| NCT02011191 |
Biotin Deficiency and Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT02011191 |
Completed |
Saint Patrick Hospital |
2007-12-31 |
| NCT01988129 |
Fire Fighter Fatigue Management Program: Operation Healthy Sleep |
https://ClinicalTrials.gov/show/NCT01988129 |
Completed |
Brigham and Women’s Hospital |
2013-09-30 |
| NCT01981941 |
Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment |
https://ClinicalTrials.gov/show/NCT01981941 |
Completed |
Astellas Pharma Inc |
2015-05-13 |
| NCT01976871 |
Switching From Oral Dopamine Agonists to Rotigotine |
https://ClinicalTrials.gov/show/NCT01976871 |
Completed |
Massachusetts General Hospital |
2015-05-31 |
| NCT01942343 |
Akathisia in Post Operative Outpatients Surgery |
https://ClinicalTrials.gov/show/NCT01942343 |
Completed |
University Hospital, Strasbourg, France |
2015-10-31 |
| NCT01931878 |
Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome. |
https://ClinicalTrials.gov/show/NCT01931878 |
Completed |
Yale University |
2015-08-31 |
| NCT01904760 |
Dexmedetomidine to Prevent Agitation After Free Flap Surgery |
https://ClinicalTrials.gov/show/NCT01904760 |
Completed |
Peking University |
2013-11-30 |
| NCT01892579 |
Reducing Agitation in People With Dementia: the Customized Activity Trial |
https://ClinicalTrials.gov/show/NCT01892579 |
Completed |
Johns Hopkins University |
2017-08-23 |
| NCT01878656 |
Comparison of Emergence Agitation Between Sevoflurane and Desflurane Anesthesia After Orthognathic Surgery |
https://ClinicalTrials.gov/show/NCT01878656 |
Completed |
Chung-Ang University Hosptial, Chung-Ang University College of Medicine |
2014-02-28 |
| NCT01862640 |
A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer’s Agitation |
https://ClinicalTrials.gov/show/NCT01862640 |
Completed |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2017-03-15 |
| NCT02025608 |
Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT02025608 |
Completed |
Ospedale Regionale di Lugano |
2016-12-31 |
| NCT01823770 |
Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT01823770 |
Completed |
University Hospital, Montpellier |
2016-07-04 |
| NCT01750541 |
Haloperidol vs. Valproate in Agitation |
https://ClinicalTrials.gov/show/NCT01750541 |
Completed |
Shahid Beheshti University of Medical Sciences |
2012-12-31 |
| NCT01735630 |
Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer’s Disease |
https://ClinicalTrials.gov/show/NCT01735630 |
Completed |
OPKO Health, Inc. |
2015-05-31 |
| NCT01715506 |
Continuing Education in Nursing Home Dementia Care |
https://ClinicalTrials.gov/show/NCT01715506 |
Completed |
Bergen University College |
2014-08-31 |
| NCT01672502 |
Fire Fighter Fatigue Management Program: Operation Fight Fatigue |
https://ClinicalTrials.gov/show/NCT01672502 |
Completed |
Brigham and Women’s Hospital |
2014-05-31 |
| NCT01668667 |
Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome Post Marketing Commitment Study |
https://ClinicalTrials.gov/show/NCT01668667 |
Completed |
XenoPort, Inc. |
2013-11-30 |
| NCT01617044 |
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome |
https://ClinicalTrials.gov/show/NCT01617044 |
Completed |
Children’s Hospitals and Clinics of Minnesota |
2015-11-30 |
| NCT01584440 |
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer’s Patients |
https://ClinicalTrials.gov/show/NCT01584440 |
Completed |
Avanir Pharmaceuticals |
2014-07-31 |
| NCT01569464 |
Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS) |
https://ClinicalTrials.gov/show/NCT01569464 |
Completed |
UCB Pharma |
2013-04-30 |
| NCT01562743 |
A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT01562743 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2010-10-31 |
| NCT01537042 |
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis |
https://ClinicalTrials.gov/show/NCT01537042 |
Completed |
UCB Pharma |
2013-10-31 |
| NCT01535287 |
Effect of Dexmedetomidine on Emergence Agitation in Children With or Without Tube Insertion Under General Anesthesia |
https://ClinicalTrials.gov/show/NCT01535287 |
Completed |
University of Iowa |
2013-10-08 |
| NCT01528891 |
Dexmedetomidine as a Rapid Bolus in Children for Emergence Agitation |
https://ClinicalTrials.gov/show/NCT01528891 |
Completed |
University of Pittsburgh |
2014-08-31 |
| NCT01521663 |
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS) |
https://ClinicalTrials.gov/show/NCT01521663 |
Completed |
Impax Laboratories, LLC |
2013-02-28 |
| NCT01517932 |
Effects of Dexmedetomidine on Stress Response and Postoperative Analgesia |
https://ClinicalTrials.gov/show/NCT01517932 |
Completed |
Huazhong University of Science and Technology |
2011-12-31 |
| NCT01517438 |
Effects of Serotonin Inhibitors on Patient-controlled Analgesia Related Nausea and Vomiting |
https://ClinicalTrials.gov/show/NCT01517438 |
Completed |
Seoul National University Hospital |
2011-12-31 |
| NCT01506622 |
Comparison Between Propofol and Fentanyl for Prevention of Emergence Agitation in Children After Sevoflurane Anesthesia |
https://ClinicalTrials.gov/show/NCT01506622 |
Completed |
Yonsei University |
2011-12-31 |
| NCT01501123 |
Pre-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient |
https://ClinicalTrials.gov/show/NCT01501123 |
Completed |
Catholic Health East |
2015-10-31 |
| NCT01498120 |
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT01498120 |
Completed |
UCB Pharma |
2015-12-31 |
| NCT01495793 |
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT01495793 |
Completed |
UCB Pharma |
2014-05-31 |
| NCT01494766 |
Efficacy of Tyrosine in Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT01494766 |
Completed |
Seton Healthcare Family |
2012-05-31 |
| NCT01485692 |
Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy Evaluation |
https://ClinicalTrials.gov/show/NCT01485692 |
Completed |
University of Sao Paulo |
2011-03-31 |
| NCT01455012 |
Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT01455012 |
Completed |
UCB Pharma |
2012-05-31 |
| NCT01440114 |
The Effect of Intravenous Fentanyl Prior the End of Surgery on Emergence Agitation in Paediatric Patients After General Anesthesia |
https://ClinicalTrials.gov/show/NCT01440114 |
Completed |
Prince of Songkla University |
2011-07-31 |
| NCT01411124 |
Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT01411124 |
Completed |
XenoPort, Inc. |
2011-10-31 |
| NCT01400113 |
Treating Acutely Agitated Patients With Asenapine Sublingual Tablets |
https://ClinicalTrials.gov/show/NCT01400113 |
Completed |
St. Joseph Hospital Health Center |
2012-12-31 |
| NCT01382901 |
Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS) |
https://ClinicalTrials.gov/show/NCT01382901 |
Completed |
American Regent, Inc. |
2007-07-31 |
| NCT01362959 |
Nicotine Replacement Therapy in the Intensive Care Unit |
https://ClinicalTrials.gov/show/NCT01362959 |
Completed |
Gelderse Vallei Hospital |
2016-08-31 |
| NCT01332318 |
Simulated Driving Study in Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT01332318 |
Completed |
XenoPort, Inc. |
2007-11-30 |
| NCT01332305 |
Dose-Response and Pharmacokinetics of Gabapentin Enacarbil (GEn [XP13512 / GSK1838262]) in Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT01332305 |
Completed |
XenoPort, Inc. |
2008-01-31 |
| NCT04316052 |
Aerobic And Strength Training Exercises For Restless Leg Syndrome In Patients With Diabetes |
https://ClinicalTrials.gov/show/NCT04316052 |
Recruiting |
Riphah International University |
2020-07-15 |
| NCT04293081 |
Preemptive Chlorepheniramine Maleate Reducing Postoperative Agitation |
https://ClinicalTrials.gov/show/NCT04293081 |
Completed |
Ain Shams University |
2019-05-31 |
| NCT04276883 |
Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder |
https://ClinicalTrials.gov/show/NCT04276883 |
Recruiting |
BioXcel Therapeutics Inc |
2020-04-30 |
| NCT04268303 |
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia |
https://ClinicalTrials.gov/show/NCT04268303 |
Recruiting |
BioXcel Therapeutics Inc |
2020-05-01 |
| NCT04251910 |
Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia |
https://ClinicalTrials.gov/show/NCT04251910 |
Recruiting |
BioXcel Therapeutics Inc |
2020-04-30 |
| NCT04142840 |
Dexmedetomidine and Propofol in the Treatment of Emergence Agitation |
https://ClinicalTrials.gov/show/NCT04142840 |
Recruiting |
RenJi Hospital |
2021-08-30 |
| NCT04112979 |
Auditory Intraoperative Stimulation Effects on Pain and Agitation at Awakening (AUDIOPAW) |
https://ClinicalTrials.gov/show/NCT04112979 |
Completed |
IRCCS Burlo Garofolo |
2019-08-23 |
| NCT04094779 |
Effect of “Breath of Fresh Air” Flash Activity on Dementia Agitation : Pilot Study |
https://ClinicalTrials.gov/show/NCT04094779 |
Recruiting |
University Hospital, Toulouse |
2020-10-20 |
| NCT04075435 |
Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Alzheimer’s Dementia |
https://ClinicalTrials.gov/show/NCT04075435 |
Recruiting |
Mclean Hospital |
2021-11-01 |
| NCT04061681 |
Efficacy of BIPAMS for Restless Legs Syndrome in Adults With Multiple Sclerosis: A Pilot Study |
https://ClinicalTrials.gov/show/NCT04061681 |
Active, not recruiting |
University of Alabama at Birmingham |
2020-07-31 |
| NCT04058899 |
Dexmedetomidine Versus Nalbuphine in Prevention of Emergence Agitation Following Adenotonsillectomy in Pediatrics |
https://ClinicalTrials.gov/show/NCT04058899 |
Active, not recruiting |
Ain Shams University |
2019-09-30 |
| NCT04018157 |
Single Bolus Dose of Ketodex Versus Ketofol For Prevention Of Emergence Agitation In Adults Undergoing Nasal Surgeries |
https://ClinicalTrials.gov/show/NCT04018157 |
Completed |
Zagazig University |
2019-11-20 |
| NCT04010305 |
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia |
https://ClinicalTrials.gov/show/NCT04010305 |
Completed |
BioXcel Therapeutics Inc |
2019-07-31 |
| NCT03992196 |
A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT03992196 |
Enrolling by invitation |
UCB Pharma |
2024-11-30 |
| NCT03862391 |
Does Low Flow Anesthesia Reduce Postanaesthetic Emergence Agitation? |
https://ClinicalTrials.gov/show/NCT03862391 |
Completed |
Sakarya University |
2019-11-01 |
| NCT03846284 |
Caudal Versus Intravenous Magnesium Sulfate on Emergence Agitation After Sevoflurane In Children. |
https://ClinicalTrials.gov/show/NCT03846284 |
Active, not recruiting |
Mansoura University |
2018-11-15 |
| NCT03817554 |
Pramipexole for Restless Leg Syndrome in Peritoneal Dialysis Patients |
https://ClinicalTrials.gov/show/NCT03817554 |
Recruiting |
Peking University First Hospital |
2022-02-01 |
| NCT03807011 |
Emergence Agitation in Pediatric Strabismus Surgery |
https://ClinicalTrials.gov/show/NCT03807011 |
Completed |
Yeungnam University College of Medicine |
2018-10-05 |
| NCT03806530 |
DIalysis Symptom COntrol-Restless Legs Syndrome Trial |
https://ClinicalTrials.gov/show/NCT03806530 |
Recruiting |
Population Health Research Institute |
2020-08-31 |
| NCT03728933 |
A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause |
https://ClinicalTrials.gov/show/NCT03728933 |
Recruiting |
UCB Pharma |
2023-10-31 |
| NCT03724942 |
Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer’s Type |
https://ClinicalTrials.gov/show/NCT03724942 |
Recruiting |
Otsuka Pharmaceutical Co., Ltd. |
2021-05-31 |
| NCT03710642 |
Prazosin for Agitation in Alzheimer’s Disease |
https://ClinicalTrials.gov/show/NCT03710642 |
Active, not recruiting |
Alzheimer’s Disease Cooperative Study (ADCS) |
2021-12-31 |
| NCT03681574 |
Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology |
https://ClinicalTrials.gov/show/NCT03681574 |
Completed |
Hospital Infantil Albert Sabin |
2018-07-01 |
| NCT03643991 |
Decreasing Agitation in Patients With Dementia Through the Use of Weighted Blankets |
https://ClinicalTrials.gov/show/NCT03643991 |
Recruiting |
Mayo Clinic |
2021-03-30 |
| NCT03624322 |
Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101 |
https://ClinicalTrials.gov/show/NCT03624322 |
Completed |
Impel NeuroPharma Inc. |
2018-10-03 |
| NCT03620981 |
Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer’s Type |
https://ClinicalTrials.gov/show/NCT03620981 |
Recruiting |
Otsuka Pharmaceutical Co., Ltd. |
2021-11-30 |
| NCT03594123 |
A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer’s Type |
https://ClinicalTrials.gov/show/NCT03594123 |
Recruiting |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2021-07-31 |
| NCT03548584 |
A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer’s Type |
https://ClinicalTrials.gov/show/NCT03548584 |
Recruiting |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2020-11-30 |
| NCT03548194 |
A Study of BNC210 in Elderly Patients With Agitation |
https://ClinicalTrials.gov/show/NCT03548194 |
Completed |
Bionomics Limited |
2019-04-23 |
| NCT03539081 |
Spinal Cord Stimulation for Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT03539081 |
Completed |
University of Iowa |
2020-04-23 |
| NCT03453814 |
Music Intervention for Agitation Reduction in the Pediatric Intensive Care Unit |
https://ClinicalTrials.gov/show/NCT03453814 |
Completed |
State University of New York at Buffalo |
2019-08-01 |
| NCT01245777 |
Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy |
https://ClinicalTrials.gov/show/NCT01245777 |
Completed |
University of Zurich |
2012-12-31 |
| NCT01235143 |
Emergence Agitation Between Sevoflurane and Desflurane in Pediatric |
https://ClinicalTrials.gov/show/NCT01235143 |
Completed |
Prince of Songkla University |
2012-08-31 |
| NCT01193816 |
Loxapine in the Management of Restlessness During Mechanical Ventilation Weaning |
https://ClinicalTrials.gov/show/NCT01193816 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2014-05-31 |
| NCT01183351 |
Multidisciplinary Intervention for Challenging Behaviour (Agitation) in Patients With Dementia |
https://ClinicalTrials.gov/show/NCT01183351 |
Completed |
Sykehuset Innlandet HF |
2011-08-31 |
| NCT02022488 |
Sevoflurane Induced Emergence Agitation |
https://ClinicalTrials.gov/show/NCT02022488 |
Completed |
Yeditepe University Hospital |
2012-08-31 |
| NCT01125033 |
Study of Vitamin C, Vitamin E and Their Combination to Treat Restless Legs Syndrome in Hemodialysis Patients |
https://ClinicalTrials.gov/show/NCT01125033 |
Completed |
Shiraz University of Medical Sciences |
2009-01-31 |
| NCT01119638 |
Escitalopram Treatment for BPSD in Alzheimer’s Disease in Comparison to Risperidone |
https://ClinicalTrials.gov/show/NCT01119638 |
Completed |
Abarbanel Mental Health Center |
2010-04-30 |
| NCT01084551 |
Study of SPM 962 in Patients With Restless Legs Syndrome (RLS) |
https://ClinicalTrials.gov/show/NCT01084551 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2011-09-30 |
| NCT01069536 |
Efficacy and Akathisia Incidence of Slow Infusion Metoclopramide |
https://ClinicalTrials.gov/show/NCT01069536 |
Completed |
Pamukkale University |
2007-03-31 |
| NCT01051271 |
Prophylaxis Against Metoclopramide-Induced Akathisia |
https://ClinicalTrials.gov/show/NCT01051271 |
Completed |
Pamukkale University |
2009-07-31 |
| NCT01050478 |
IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation |
https://ClinicalTrials.gov/show/NCT01050478 |
Completed |
Janssen Cilag N.V./S.A. |
2011-12-31 |
| NCT01021696 |
Pain in Patients With Dementia and Behavioural Disturbances |
https://ClinicalTrials.gov/show/NCT01021696 |
Completed |
University of Bergen |
2010-07-31 |
| NCT00991276 |
Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance |
https://ClinicalTrials.gov/show/NCT00991276 |
Completed |
Pfizer |
2011-06-30 |
| NCT00990769 |
The Effect of Depth of Anesthesia as Measured by Bispectral Index (BIS) on Emergence Agitation in Children |
https://ClinicalTrials.gov/show/NCT00990769 |
Completed |
Duke University |
2010-09-30 |
| NCT00949806 |
Restless Legs Syndrome Treatment With Botulinum Toxin |
https://ClinicalTrials.gov/show/NCT00949806 |
Completed |
University Hospital, Bordeaux |
2011-05-31 |
| NCT00942253 |
Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS) |
https://ClinicalTrials.gov/show/NCT00942253 |
Completed |
University of Thessaly |
2010-04-30 |
| NCT00932685 |
Does Distraction With a Hand Held Video Game Reduce Preoperative and Emergence Anxiety in Children? |
https://ClinicalTrials.gov/show/NCT00932685 |
Completed |
Rutgers, The State University of New Jersey |
2007-06-30 |
| NCT00898807 |
Citalopram for Agitation in Alzheimer’s Disease |
https://ClinicalTrials.gov/show/NCT00898807 |
Completed |
JHSPH Center for Clinical Trials |
2013-09-30 |
| NCT00895232 |
Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments |
https://ClinicalTrials.gov/show/NCT00895232 |
Completed |
American Regent, Inc. |
2005-08-31 |
| NCT00872248 |
Neuraxial Anesthesia and Restless Leg Syndromes in Cesarean |
https://ClinicalTrials.gov/show/NCT00872248 |
Completed |
Nanjing Medical University |
2011-05-31 |
| NCT00866645 |
A Study To Evaluate The Efficacy And Safety Of Intramuscular Levosulpiride In Patients With Agitation Of Schizophrenia |
https://ClinicalTrials.gov/show/NCT00866645 |
Completed |
Shanghai Mental Health Center |
2010-07-31 |
| NCT00859872 |
Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia |
https://ClinicalTrials.gov/show/NCT00859872 |
Completed |
Central South University |
2009-03-31 |
| NCT00857727 |
Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children |
https://ClinicalTrials.gov/show/NCT00857727 |
Completed |
St. Luke’s-Roosevelt Hospital Center |
2011-11-30 |
| NCT00843518 |
Treatment for Aggression and Agitation in Patients With Alzheimer’s Disease |
https://ClinicalTrials.gov/show/NCT00843518 |
Completed |
Eli Lilly and Company |
2011-06-30 |
| NCT03345953 |
Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT03345953 |
Recruiting |
Bioprojet |
2020-03-01 |
| NCT01848158 |
Acupuncture to Improve Comfort of Children on a Ventilator in the Intensive Care Unit |
https://ClinicalTrials.gov/show/NCT01848158 |
Completed |
Seattle Children’s Hospital |
2016-06-30 |
| NCT00806026 |
Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients |
https://ClinicalTrials.gov/show/NCT00806026 |
Completed |
Pfizer |
2011-05-31 |
| NCT04347668 |
Can Virtual Reality Reduce Depression and Agitation in Older Adults With Moderate to Severe Dementia? |
https://ClinicalTrials.gov/show/NCT04347668 |
Recruiting |
Western University, Canada |
2020-05-01 |
| NCT03528954 |
Propofol to Reduce the Incidence of Postanesthetic Emergence Agitation in Pediatric Patients Under General Anesthesia |
https://ClinicalTrials.gov/show/NCT03528954 |
Completed |
Indonesia University |
2018-08-31 |
| NCT03226522 |
Addressing Dementia Via Agitation-Centered Evaluation |
https://ClinicalTrials.gov/show/NCT03226522 |
Recruiting |
Axsome Therapeutics, Inc. |
2020-06-30 |
| NCT03213782 |
Effect of Nature Based Sounds’ Intervention on Agitation and Anxiety of Patients Admitted in Intensive Care Units. |
https://ClinicalTrials.gov/show/NCT03213782 |
Completed |
Maharishi Markendeswar University (Deemed to be University) |
2017-01-07 |
| NCT02027844 |
Cartoon Distraction and Parental Presence on Anxiety in Pediatric Anesthesia |
https://ClinicalTrials.gov/show/NCT02027844 |
Completed |
Yeungnam University College of Medicine |
2015-06-30 |
| NCT04312893 |
The Effectiveness of Acupuncture for Delirium in Critically Ill Patients |
https://ClinicalTrials.gov/show/NCT04312893 |
Recruiting |
China Medical University Hospital |
2022-05-30 |
| NCT00790075 |
Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children |
https://ClinicalTrials.gov/show/NCT00790075 |
Completed |
Stony Brook University |
2004-06-30 |
| NCT00748098 |
Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance |
https://ClinicalTrials.gov/show/NCT00748098 |
Completed |
XenoPort, Inc. |
2009-07-31 |
| NCT00723606 |
A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation |
https://ClinicalTrials.gov/show/NCT00723606 |
Completed |
Pfizer |
2009-07-31 |
| NCT00723580 |
Actigraphic Analysis of Treatment Response |
https://ClinicalTrials.gov/show/NCT00723580 |
Completed |
Child Psychopharmacology Institute |
2010-07-31 |
| NCT00685815 |
Intravenous Iron Metabolism in Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00685815 |
Completed |
American Regent, Inc. |
2010-12-31 |
| NCT00676403 |
Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients |
https://ClinicalTrials.gov/show/NCT00676403 |
Completed |
Pfizer |
2009-01-31 |
| NCT00666965 |
A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients |
https://ClinicalTrials.gov/show/NCT00666965 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2009-08-31 |
| NCT00654498 |
Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS) |
https://ClinicalTrials.gov/show/NCT00654498 |
Completed |
Boehringer Ingelheim |
2009-06-30 |
| NCT00628589 |
Staccato Loxapine in Agitated Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00628589 |
Completed |
Alexza Pharmaceuticals, Inc. |
2008-05-31 |
| NCT00627003 |
A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS |
https://ClinicalTrials.gov/show/NCT00627003 |
Completed |
Pfizer |
NA |
| NCT00626418 |
The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00626418 |
Completed |
Ligand Pharmaceuticals |
2008-10-31 |
| NCT00625547 |
A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS |
https://ClinicalTrials.gov/show/NCT00625547 |
Completed |
Pfizer |
NA |
| NCT00621647 |
Seroquel- Agitation Associated With Dementia |
https://ClinicalTrials.gov/show/NCT00621647 |
Completed |
AstraZeneca |
2003-11-30 |
| NCT00621517 |
Bupropion and Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00621517 |
Completed |
East Tennessee State University |
2009-07-31 |
| NCT00535613 |
Propofol in Emergence Agitation |
https://ClinicalTrials.gov/show/NCT00535613 |
Completed |
University of Wisconsin, Madison |
2010-12-31 |
| NCT00530790 |
Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00530790 |
Completed |
GlaxoSmithKline |
2008-02-01 |
| NCT00530530 |
ASP8825 - Study in Patients With Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00530530 |
Completed |
Astellas Pharma Inc |
2009-01-31 |
| NCT00505804 |
A Comparison of Dexmedetomidine and Haloperidol in Patients With Intensive Care Unit (ICU)-Associated Agitation and Delirium |
https://ClinicalTrials.gov/show/NCT00505804 |
Completed |
Austin Health |
2008-11-30 |
| NCT00498186 |
Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS) |
https://ClinicalTrials.gov/show/NCT00498186 |
Completed |
UCB Pharma |
2009-04-30 |
| NCT00498108 |
Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects |
https://ClinicalTrials.gov/show/NCT00498108 |
Completed |
UCB Pharma |
2007-09-30 |
| NCT00479531 |
Sequential Compression Devices for Treatment of Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00479531 |
Completed |
Walter Reed Army Medical Center |
NA |
| NCT00479154 |
Botulinum Toxin to Treat Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00479154 |
Completed |
National Institutes of Health Clinical Center (CC) |
2008-04-30 |
| NCT00472199 |
Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS) |
https://ClinicalTrials.gov/show/NCT00472199 |
Completed |
Boehringer Ingelheim |
2008-07-31 |
| NCT00419692 |
Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food |
https://ClinicalTrials.gov/show/NCT00419692 |
Completed |
GlaxoSmithKline |
2006-12-12 |
| NCT00417482 |
Antipsychotic Discontinuation in Alzheimer’s Disease |
https://ClinicalTrials.gov/show/NCT00417482 |
Completed |
New York State Psychiatric Institute |
2011-04-30 |
| NCT00409370 |
Trial of Safety Nets In Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT00409370 |
Completed |
Griffin Hospital |
NA |
| NCT00390689 |
A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS. |
https://ClinicalTrials.gov/show/NCT00390689 |
Completed |
Boehringer Ingelheim |
2008-03-31 |
| NCT00389831 |
Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms |
https://ClinicalTrials.gov/show/NCT00389831 |
Completed |
UCB Pharma |
2006-11-30 |
| NCT00375284 |
A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS |
https://ClinicalTrials.gov/show/NCT00375284 |
Completed |
Boehringer Ingelheim |
2007-07-31 |
| NCT00373542 |
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00373542 |
Completed |
GlaxoSmithKline |
2007-06-30 |
| NCT00369577 |
Staccato Loxapine in Agitation (Proof of Concept) |
https://ClinicalTrials.gov/show/NCT00369577 |
Completed |
Alexza Pharmaceuticals, Inc. |
2007-01-31 |
| NCT00367822 |
Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS) |
https://ClinicalTrials.gov/show/NCT00367822 |
Completed |
Axxonis Pharma AG |
NA |
| NCT00365352 |
XP13512 vs. Placebo in Patients With Restless Legs Syndrome. |
https://ClinicalTrials.gov/show/NCT00365352 |
Completed |
XenoPort, Inc. |
2007-12-31 |
| NCT00363857 |
A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00363857 |
Completed |
GlaxoSmithKline |
2004-05-31 |
| NCT00357097 |
The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00357097 |
Completed |
GlaxoSmithKline |
2007-12-31 |
| NCT00356096 |
Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances |
https://ClinicalTrials.gov/show/NCT00356096 |
Completed |
Boehringer Ingelheim |
2007-06-30 |
| NCT00355641 |
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00355641 |
Completed |
GlaxoSmithKline |
2007-10-31 |
| NCT00351299 |
Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium |
https://ClinicalTrials.gov/show/NCT00351299 |
Completed |
Brigham and Women’s Hospital |
2012-10-31 |
| NCT00349531 |
A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS |
https://ClinicalTrials.gov/show/NCT00349531 |
Completed |
Boehringer Ingelheim |
2007-05-31 |
| NCT00344994 |
SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole |
https://ClinicalTrials.gov/show/NCT00344994 |
Completed |
Augusta University |
2007-09-30 |
| NCT00333359 |
XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome. |
https://ClinicalTrials.gov/show/NCT00333359 |
Completed |
XenoPort, Inc. |
2008-12-31 |
| NCT00329602 |
Long-term Study Of Ropinirole In Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00329602 |
Completed |
GlaxoSmithKline |
2008-09-30 |
| NCT00314860 |
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole |
https://ClinicalTrials.gov/show/NCT00314860 |
Completed |
GlaxoSmithKline |
2006-12-31 |
| NCT00311363 |
Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome. |
https://ClinicalTrials.gov/show/NCT00311363 |
Completed |
XenoPort, Inc. |
2007-11-30 |
| NCT00298623 |
XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome. |
https://ClinicalTrials.gov/show/NCT00298623 |
Completed |
XenoPort, Inc. |
2007-02-28 |
| NCT00275457 |
Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients |
https://ClinicalTrials.gov/show/NCT00275457 |
Completed |
Boehringer Ingelheim |
2004-04-30 |
| NCT00275236 |
A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00275236 |
Completed |
UCB Pharma |
2006-07-31 |
| NCT00263068 |
An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00263068 |
Completed |
UCB Pharma |
2007-12-31 |
| NCT00260624 |
Escitalopram Treatment of Patients With Agitated Dementia |
https://ClinicalTrials.gov/show/NCT00260624 |
Completed |
University of Rochester |
2006-12-31 |
| NCT00256854 |
Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome) |
https://ClinicalTrials.gov/show/NCT00256854 |
Completed |
GlaxoSmithKline |
2006-09-21 |
| NCT00247364 |
A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS) |
https://ClinicalTrials.gov/show/NCT00247364 |
Completed |
Sleep Health Centers |
NA |
| NCT00243217 |
Rotigotine Restless Legs Syndrome Dose Finding Trial |
https://ClinicalTrials.gov/show/NCT00243217 |
Completed |
UCB Pharma |
2004-02-29 |
| NCT00239486 |
Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS) |
https://ClinicalTrials.gov/show/NCT00239486 |
Completed |
Boehringer Ingelheim |
2004-04-30 |
| NCT00225862 |
A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS) |
https://ClinicalTrials.gov/show/NCT00225862 |
Completed |
GlaxoSmithKline |
NA |
| NCT00208819 |
A Comparison of Two Standard Therapies in the Management of Dementia With Agitation |
https://ClinicalTrials.gov/show/NCT00208819 |
Completed |
Emory University |
NA |
| NCT00200941 |
Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00200941 |
Completed |
Neurocare |
NA |
| NCT00199446 |
Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00199446 |
Completed |
Kyowa Kirin Pharmaceutical Development, Inc. |
2006-08-31 |
| NCT00197080 |
Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00197080 |
Completed |
GlaxoSmithKline |
NA |
| NCT00161473 |
Alzheimer’s in Long-Term Care–Treatment for Agitation |
https://ClinicalTrials.gov/show/NCT00161473 |
Completed |
University of Washington |
2009-09-30 |
| NCT00152997 |
Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00152997 |
Completed |
Boehringer Ingelheim |
2005-12-31 |
| NCT00152958 |
A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.) |
https://ClinicalTrials.gov/show/NCT00152958 |
Completed |
Boehringer Ingelheim |
2005-02-28 |
| NCT00145691 |
The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD) |
https://ClinicalTrials.gov/show/NCT00145691 |
Completed |
Sykehuset Innlandet HF |
NA |
| NCT00144209 |
Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00144209 |
Completed |
Boehringer Ingelheim |
2005-02-28 |
| NCT00140712 |
Ropinirole Tablets In Young Patients With Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00140712 |
Completed |
GlaxoSmithKline |
2008-02-28 |
| NCT00136045 |
Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome |
https://ClinicalTrials.gov/show/NCT00136045 |
Completed |
UCB Pharma |
2006-08-31 |
| NCT00135993 |
Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome |
https://ClinicalTrials.gov/show/NCT00135993 |
Completed |
UCB Pharma |
2006-11-30 |
| NCT00133198 |
Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS) |
https://ClinicalTrials.gov/show/NCT00133198 |
Completed |
Boehringer Ingelheim |
2005-02-28 |
| NCT00122733 |
Loxapine and Weaning From Ventilator |
https://ClinicalTrials.gov/show/NCT00122733 |
Completed |
Assistance Publique - Hôpitaux de Paris |
NA |
| NCT00797277 |
Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia |
https://ClinicalTrials.gov/show/NCT00797277 |
Completed |
National Taiwan University Hospital |
2009-06-30 |
| NCT00043849 |
Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP) |
https://ClinicalTrials.gov/show/NCT00043849 |
Completed |
National Institute on Aging (NIA) |
2005-06-30 |
| NCT00009217 |
Treatment of Behavioral Symptoms in Alzheimer’s Disease |
https://ClinicalTrials.gov/show/NCT00009217 |
Completed |
New York State Psychiatric Institute |
2004-12-31 |
| NCT00009204 |
Serotonergic Pharmacotherapy for Agitation of Dementia |
https://ClinicalTrials.gov/show/NCT00009204 |
Completed |
University of Pittsburgh |
2000-04-30 |